Riskpilot← Back to searchSign inGet full accessLars Rasmusson AB
ABActiveOrg 5567795215Blomstervägen 2Hospital activities · NACE 8610Est. 20091-4 employees
Revenue 2025
SEK 2,6M
-16% vs 2024
EBITDA margin
29.1%
+19% vs 2024
Equity ratio
89.7%
Financial strength
Net profit 2025
SEK 577K
+16% vs 2024
| Revenue | SEK 2,6M | -16% |
| EBITDA | SEK 770K | +19% |
| Net profit | SEK 577K | +16% |
| Total assets | SEK 3,9M | +8% |
| Equity | SEK 3,5M | +12% |
| Employees | — | — |
Legal name
Lars Rasmusson AB
Org number
5567795215
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 mars 2009
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rasmusson, Lars Gösta Ingemar
Company purpose
Bolaget ska bedriva forskningsuppdrag, rådgivning, föreläsnings- och utbildningsuppdrag samt klinisk verksamhet inom medicinteknik och läkemedelsindustrin samt därmed förenlig verksamhet.
Address
Blomstervägen 2
Phone
+4631933288
Email
lars.rasmusson@gu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 890 | 3 226 | 2 898 | 3 128 | 2 642 |
| Staff expenses | — | — | — | −990 | −487 |
| EBITDA | 1 242 | 1 422 | 1 063 | 645 | 770 |
| Depreciation & amort. | −114 | −86 | −7 | −7 | −35 |
| EBIT | 1 128 | 1 336 | 1 056 | 638 | 735 |
| Net financials | −25 | −19 | −10 | −2 | −1 |
| Profit before tax | 1 102 | 1 317 | 1 046 | 636 | 735 |
| Tax | −242 | −281 | −225 | −137 | 158 |
| Net profit | 860 | 1 036 | 821 | 498 | 577 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 813 | 3 142 | 3 161 | 3 626 | 3 911 |
| Equity | 1 616 | 2 252 | 2 843 | 3 141 | 3 508 |
| Long-term debt | 864 | 450 | 57 | 49 | 225 |
| Short-term debt | 202 | 310 | 131 | 306 | 48 |
| Total debt | 1 066 | 760 | 188 | 355 | 273 |
EBITDA margin
29.1%
This company
15.8%
Market median
+84% vs market
20212025
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
20212025
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20212025
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lars Rasmusson AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stellan Anders Jeanson | Audit | 0 companies |
| Lars Gösta Ingemar Rasmusson | Chairman | 0 companies |
| Anna Sofia Elisabeth Rasmusson | Board of Directors | 0 companies |
| Carl Anders Fredrik Rasmusson | Board of Directors | 0 companies |
| Sara Inger Lovisa Rasmusson | Board of Directors | 0 companies |